World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
36361
World Ranking
9249
National Ranking
900

Overview

Roger A'Hern is affiliated with the Royal Marsden NHS Foundation Trust in the United Kingdom. Their research primarily spans the field of Medicine, with a focus on Oncology, Surgery, and Genetics as key subfields. The main topics in their work include Cancer Treatment and Pharmacology, Constructed Wetlands for Wastewater Treatment, Coastal Wetland Ecosystem Dynamics, Wastewater Treatment and Nitrogen Removal, Nerve Injury and Rehabilitation, Peripheral Nerve Disorders, and Statistical Methods in Clinical Trials.

The following papers authored or co-authored by Roger A'Hern have appeared in academic journals and research platforms:

  • Employing multiple synchronous outcome samples per subject to improve study efficiency, 2021, BMC Medical Research Methodology
  • Employing Multiple Synchronous Outcome Samples Per Subject to Improve Study Efficiency., 2021, Research Square (Research Square)
  • 'I presumed the pain would eventually get better by itself'; challenges with access to rehabilitation for upper limb dysfunction after breast cancer treatment - Descriptive and qualitative findings from a cross-sectional survey, 2024, European Journal of Surgical Oncology
  • Sickle Eye Project: a cross-sectional, non-interventional study of the prevalence of visual impairment due to sickle cell retinopathy and maculopathy in the UK, 2024, BMJ Open
  • Flow Rate and Water Depth Alters Biomass Production and Phytoremediation Capacity of Lemna minor, 2022, Plants

Roger A'Hern has collaborated frequently with several co-authors, including:

  • Marie-Clare Johnson
  • Alison H. McGregor
  • Daniel Leff
  • Mary Wells
  • Neil E. Coughlan

Their work has been published in various venues, reflecting the interdisciplinary nature of their research:

  • European Journal of Surgical Oncology
  • Plants
  • BMC Medical Research Methodology
  • BMJ Open
  • Research Square (Research Square)

Best Publications

  • DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.

    Joaquin Mateo;Suzanne Carreira;Shahneen Sandhu;Susana Miranda

  • Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

    Mitch Dowsett;Torsten O. Nielsen;Roger A’Hern;John Bartlett

  • Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

    Christopher M Nutting;Christopher M Nutting;James P Morden;Kevin J Harrington;Kevin J Harrington;Teresa Guerrero Urbano

  • Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval

    Peter C. Fong;Timothy A. Yap;David S. Boss;Craig P. Carden

  • Prognostic Value of Ki67 Expression After Short-Term Presurgical Endocrine Therapy for Primary Breast Cancer

    Mitch Dowsett;Ian E. Smith

  • Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer

    Gerhardt Attard;Alison H.M. Reid;Roger A'Hern;Christopher Parker

  • Outcome Prediction for Estrogen Receptor–Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics

    Matthew J. Ellis;Yu Tao;Jingqin Luo;Roger A'Hern

  • Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer

    Gerhardt Attard;Joost F. Swennenhuis;David Olmos;Alison H.M. Reid

  • Excision margins in high-risk malignant melanoma.

    J. Meirion Thomas;Julia Newton-Bishop;Roger A'Hern;Gill Coombes

  • Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer.

    T Eisen;C Boshoff;C Boshoff;I Mak;F Sapunar

  • Analgesic Therapy in Postherpetic Neuralgia: A Quantitative Systematic Review

    Kathleen Hempenstall;Turo J Nurmikko;Robert W Johnson;Roger P A'Hern

  • Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).

    Elisabeth J. Moreau;Estella Matutes;Roger P. A’Hern;Alison M. Morilla

  • Breast cancer molecular profiling with single sample predictors: a retrospective analysis

    Britta Weigelt;Alan Mackay;Roger A'hern;Rachael Natrajan

  • Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer.

    S.J. Cawthorn;S.M. Caffarey;C.I.M. Broughton;C.G. Marks

  • Synovial Sarcoma: A Clinicopathologic, Staging, and Prognostic Assessment

    Andrew J. Spillane;Roger A’Hern;Ian R. Judson;Cyril Fisher

  • Oral Nutritional Interventions in Malnourished Patients With Cancer: A Systematic Review and Meta-Analysis

    Christine Baldwin;Ayelet Spiro;Roger Ahern;Peter W. Emery

  • A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer

    P. Stone;M. Richards;R. A'Hern;J. Hardy

  • The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity

    A.M. Moody;W.P.M. Mayles;J.M. Bliss;R.P. A'Hern

  • Mucinous Epithelial Ovarian Cancer: A Separate Entity Requiring Specific Treatment

    Viviane Hess;Roger A'Hern;Nazar Nasiri;D. Michael King

  • Fatigue in advanced cancer: a prospective controlled cross-sectional study

    P Stone;J Hardy;K Broadley;A J Tookman

Frequent Co-Authors

Mitch Dowsett
Mitch Dowsett Breast Cancer Research Foundation
Martin Gore
Martin Gore Royal Marsden NHS Foundation Trust
Kevin J. Harrington
Kevin J. Harrington Royal Marsden NHS Foundation Trust
Cyril Fisher
Cyril Fisher Royal Marsden NHS Foundation Trust
Christopher M. Nutting
Christopher M. Nutting Royal Marsden NHS Foundation Trust
David P. Dearnaley
David P. Dearnaley Institute of Cancer Research
Judith M. Bliss
Judith M. Bliss Institute of Cancer Research
Rosalind A. Eeles
Rosalind A. Eeles Institute of Cancer Research
Daniel Catovsky
Daniel Catovsky Institute of Cancer Research
John Yarnold
John Yarnold Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA often opens doors to related health fields that offer flexible, online pathways. Many students begin by considering nursing programs. When looking into entry-level roles, it’s important to ask, do you have to take a teas test for lpn? Some schools now offer alternative routes, making nursing more accessible.

For those interested in leadership roles, healthcare administration degree programs provide skills for managing hospitals, clinics, or healthcare systems. These fast, flexible online options are popular with students balancing work and study.

Registered nurses looking to advance may explore rn to np bridge programs, empowering them to become nurse practitioners more efficiently than traditional tracks. This accelerates career growth while expanding clinical expertise.

If you have a passion for wellness and preventive care, consider online nutrition degrees. These programs prepare graduates for roles in healthcare settings, community outreach, or private consulting.

Each of these pathways can broaden your healthcare career options, whether you pursue medicine or choose a complementary health field.

Best Scientists Citing Roger A'Hern

Trending Scientists

Recently Published Articles